1.35 USD
↗ 0.05 (3.85%)AT CLOSE (11:59 AM EDT)
Pacific Biosciences of California, Inc. (PACB) is currently trading at $1.34. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, exceptional Return on Equity (395.6%) and a bearish Death Cross on the long-term moving averages. On valuation, PACB trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Sep 14, 2026.